title: Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
authors.affiliation: Clinica Medica e Gastroenterologia - Università di Bologna, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Mazzella
authors.forename: N
authors.initials: N
authors.lastname: Villanova
authors.forename: M A
authors.initials: MA
authors.lastname: Amed
authors.forename: L
authors.initials: L
authors.lastname: Barbara
authors.forename: G
authors.initials: G
authors.lastname: Saracco
authors.forename: M
authors.initials: M
authors.lastname: Rizzetto
authors.forename: C
authors.initials: C
authors.lastname: Cancellieri
authors.forename: E
authors.initials: E
authors.lastname: Roda
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D018849:Controlled Clinical Trials as Topic; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006513:Hepatitis B e Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use*; D008111:Liver Function Tests; D018579:Patient Selection; D011994:Recombinant Proteins
chemical_list: D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D007370:Interferon Type I; D016898:Interferon-alpha; D011994:Recombinant Proteins